Gelonghui reported on June 20 that Hengrui Pharmaceuticals (600276.SH) announced that the company and its subsidiaries Suzhou Shengdiya CNI Biomedicine Index Co., Ltd., Shanghai Hengrui Pharmaceuticals Co., Ltd., and Shanghai Shengdi Pharmaceuticals Co., Ltd. have received the approval notice for clinical trials from the National Medical Products Administration for SHR2554 tablets, injectable SHR-A1811, injectable SHR-A2102, Adalimumab injection, injectable SHR-A1904, and SHR-1701 injection, which will commence clinical trials in the near future.
Hengrui Pharmaceuticals (600276.SH): Received the drug clinical trial approval notice.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Discussing
The tariff deferral period has been extended! How have trade policies in various countries evolved?
Recently, U.S. President Trump announced that the period for "reciprocal tariffs" would be postponed from July 9 to August 1, and declared t
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"
Investment Course
Essential Crypto strategies to learn for beginners.
Beginner's Guide: Understand how to invest in Crypto in 3 minutes.
Crypto, in simple terms, is a virtual currency based on cryptographic principles to ensure transaction security. Unlike the money we use daily, Crypto does not
How to Trade Crypto on Futubull
Step 1: Activate the Cryptos Account. Comprehensive Account > More > Account Management > Activate Trading Products > Select [Cryptos] to start the process. Not
A comprehensive review of crypto history
Have you heard the latest about Bitcoin? In 2024 H1, its value once surged by 68% . As the largest and most well-known cryptocurrency, Bitcoin has increased in